138 related articles for article (PubMed ID: 7520658)
21. Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma.
Jang G; Ko OB; Kim S; Lee DH; Huh J; Suh C
Transfusion; 2008 Apr; 48(4):640-6. PubMed ID: 18194384
[TBL] [Abstract][Full Text] [Related]
22. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
23. Biotherapy with interferon in hematologic malignancies.
Roth MS; Foon KA
Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
[No Abstract] [Full Text] [Related]
24. Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution.
Ketterer N; Sonet A; Dumontet C; Moullet I; Thieblemont C; Espinouse D; Bouafia F; Coiffier B; Salles G
Bone Marrow Transplant; 1999 Jun; 23(12):1309-15. PubMed ID: 10414921
[TBL] [Abstract][Full Text] [Related]
25. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
[TBL] [Abstract][Full Text] [Related]
26. [Therapy of low-grade non-Hodgkin lymphomas].
Hiddemann W; Unterhalt M; Wörmann B
Praxis (Bern 1994); 1996 Mar; 85(12):357-63. PubMed ID: 8643898
[TBL] [Abstract][Full Text] [Related]
27. [Therapy of low-grade non-Hodgkin's lymphoma].
Heinz R; Hopfinger-Limberger G
Wien Klin Wochenschr; 1994; 106(10):321-6. PubMed ID: 8053200
[TBL] [Abstract][Full Text] [Related]
28. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of combining ATRA with G-CSF in HSPC mobilization; a pilot study in multiple myeloma and non-Hodgkin's lymphoma patients.
Herbert KE; True S; McArthur G; Prince HM
Bone Marrow Transplant; 2007 Oct; 40(8):801-3. PubMed ID: 17680017
[No Abstract] [Full Text] [Related]
30. Treatment options for primary splenic low-grade non-Hodgkin's lymphomas.
Musteata VG; Corcimaru IT; Iacovleva IA; Musteata LZ; Suharschii IS; Antoci LT
Clin Lab Haematol; 2004 Dec; 26(6):397-401. PubMed ID: 15595997
[TBL] [Abstract][Full Text] [Related]
31. [Primary cerebral non-Hodgkin's lymphomas. The results of radiotherapy].
Hetzel-Sesterheim M; Schnabel K; Nestle U; Hamann G; Berberich W
Strahlenther Onkol; 1996 Apr; 172(4):198-204. PubMed ID: 8623082
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of early stage primary tonsil non-Hodgkin's lymphoma].
Gao YH; Li YX; Zhao LJ; Yuan ZY; Liu XF; Yu ZH
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):190-2. PubMed ID: 12864949
[TBL] [Abstract][Full Text] [Related]
33. [Various aspects and results of therapy with interferon].
Niederle N
Arzneimittelforschung; 1988 Mar; 38(3A):449-53. PubMed ID: 2456071
[TBL] [Abstract][Full Text] [Related]
34. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
35. [Non-Hodgkin's lymphoma of the thyroid gland--2 case reports].
Milosević R; Antonijević N; Mihaljević B; Milivojević G; Petrović M; Jovanović V; Colović M
Srp Arh Celok Lek; 1996; 124(11-12):318-20. PubMed ID: 9132968
[TBL] [Abstract][Full Text] [Related]
36. Intensive chemotherapy plus hematopoietic stem cells transplantation for relapsing non-Hodgkin's lymphoma: the GELA experience.
Bosly A; Gisselbrecht C; Coiffier B
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):21-3. PubMed ID: 8099732
[TBL] [Abstract][Full Text] [Related]
37. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
Laport GF; Williams SF
Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600
[TBL] [Abstract][Full Text] [Related]
38. [Survival after high-dose therapy with autologous stem cell support].
Liseth K; Abrahamsen JF; Ekanger R; Nesthus I; Sjo MS
Tidsskr Nor Laegeforen; 2004 May; 124(10):1374-5. PubMed ID: 15195173
[TBL] [Abstract][Full Text] [Related]
39. [Interferons in cancerology. Focus in 1988].
Boiron M
Pathol Biol (Paris); 1989 Feb; 37(2):92-3. PubMed ID: 2652080
[No Abstract] [Full Text] [Related]
40. [The use of thymostimulin in lymphoma and myeloma patients].
Cánovas Fernández A; Alonso Alonso J; González de Zárate P; García Masdevall MD; Riñón Martínez-Gallo M; Aguirre Errasti C
An Med Interna; 1991 Feb; 8(2):69-73. PubMed ID: 1893006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
